Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

14 1 Search for Universal Tumor-Associated T Cell Epitopes
19 Renkvist, N., Castelli, C., Robbins,
P. F. and Parmiani, G. A listing of human
tumor antigens recognized by T
cells, Cancer Immunol Immunother 50:
3±15, 2001.
20 Sturniolo,T., Bono, E., Ding, J., Raddrizzani,
L.,Tuereci, O., Sahin, U.,
Braxenthaler, M., Gallazzi, F., Protti,
M. P., Sinigaglia, F. and Hammer, J.
Generation of tissue-specific and promiscuous
HLA ligand databases using DNA
microarrays and virtual HLA class II, Nat
Biotechnol 17: 555±561, 1999.
21 Theobald, M., Biggs, J., Hernandez, J.,
Lustgarten, J., Labadie, C. and Sherman,
L. A. Tolerance to p53 by A2.1-restricted
cytotoxic T lymphocytes, JExp
Med 185: 833±41, 1997.
22 Sherman, L. A., Morgan, D. J., Nugent,
C. T., Hernandez, F. J., Kreuwel,
H. T., Murtaza, A., Ko, A. and Biggs, J.
Self-tolerance and the composition of T
cell repertoire, Immunol Res 21: 305±13,
2000.
23 Molldrem, J. J., Lee, P. P.,Wang, C.,
Felio, K., Kantarjian, H. M., Champlin,
R. E. and Davis, M. M. Evidence
that specific T lymphocytes may participate
in the elimination of chronic myelogenous
leukemia, Nat Med 6: 1018±23,
2000.
24 Andersen, M. H., Pedersen, L. O.,
Becker, J. C. and Straten, P. T. Identification
of a cytotoxic T lymphocyte response
to the apoptosis inhibitor protein
survivin in cancer patients, Cancer Res
61: 869±72, 2001.
25 Ressing, M. E., Sette, A., Brandt, R.
M., Ruppert, J.,Wentworth, P. A.,
Hartman, M., Oseroff, C., Grey, H. M.,
Melief, C. J. and Kast,W. M. Human
CTL epitopes encoded by human papillomavirus
type 16 E6 and E7 identified
through in vivo and in vitro immunogenicity
studies of HLA-A*0201-binding
peptides, JImmunol 154: 5934±43,
1995.
26 Trojan, A., Schultze, J. L.,Witzens, M.,
Vonderheide, R. H., Ladetto, M., Donovan,
J. and Gribben, J. G. Immunoglobulin
framework-derived peptides
function as cytotoxic Tcell epitopes commonly
expressed in B cell malignancies,
Nat. Med. 6: 667±672, 2000.
27 Romero, P., Dunbar, P. R.,Valmori, D.,
Pittet, M., Ogg, G. S., Rimoldi, D.,
Chen, J. L., Lienard, D., Cerottini, J. C.
and Cerundolo,V. Ex vivo staining of
metastatic lymph nodes by class Imajor
histocompatibility complex tetramers reveals
high numbers of antigen-experienced
tumor-specific cytolytic T lymphocytes,
JExp Med 188: 1641±50, 1998.
28 Vonderheide, R. H., Hahn,W. C.,
Schultze, J. L. and Nadler, L. M. The
telomerase catalytic subunit is a widely
expressed tumor-associated antigen recognized
by cytotoxic T lymphocytes,
Immunity 10: 673±9, 1999.
29 Kim, N. W., Piatyszek, M. A., Prowse,
K. R., Harley, C. B.,West, M. D., Ho,
P. L., Coviello, G. M.,Wright,W. E.,
Weinrich, S. L. and Shay, J. W. Specific
association of human telomerase activity
with immortal cells and cancer, Science
266: 2011±5, 1994.
30 Shay, J. W. and Bacchetti, S. A survey
of telomerase activity in human cancer,
Eur JCancer 33: 787±91, 1997.
31 Kolquist, K. A., Ellisen, L. W., Counter,
C. M., Meyerson, M., Tan, L. K.,
Weinberg, R. A., Haber, D. A. and Gerald,W.
L. Expression of TERT in early
premalignant lesions and a subset of
cells in normal tissues, Nat Genet 19:
182±6, 1998.
32 Minev, B., Hipp, J., Firat, H., Schmidt,
J. D., Langlade-Demoyen, P. and Zanetti,
M. Cytotoxic T cell immunity
against telomerase reverse transcriptase
in humans, Proc Natl Acad Sci USA 97:
4796±801, 2000.
33 Nair, S. K., Heiser, A., Boczkowski, D.,
Majumdar, A., Naoe, M., Lebkowski,
J. S.,Vieweg, J. and Gilboa, E. Induction
of cytotoxic T lymphocyte responses
and tumor immunity against unrelated
tumors using telomerase reverse transcriptase
RNA transfected dendritic
cells, Nat Med 6: 1011±7, 2000.
34 Heiser, A., Maurice, M. A.,Yancey,
D. R.,Wu, N. Z., Dahm, P., Pruitt,
S. K., Boczkowski, D., Nair, S. K.,
Ballo, M. S., Gilboa, E. and Vieweg, J.
Induction of polyclonal prostate cancerspecific
CTL using dendritic cells transfected
with amplified tumor RNA, JImmunol
166: 2953±60, 2001.